Top-line results from the randomized, double-blind confirmatory Phase III study (ERADICATE Hp2 study) with ...
AMES, Iowa, Oct. 20, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that ...
TEL AVIV, Israel, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (Nasdaq:APOP) (TASE:APOP), ...
